SHR-1906

· Guangdong Hengrui Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-1906, covering 2025-03-24 to 2025-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis [Phase 2]